Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipase family member N (LIPN) is an enzyme belonging to the triglyceride lipase family, involved in hydrolyzing triglycerides into fatty acids and glycerol, thereby playing a key role in lipid metabolism and digestion. LIPN is predominantly expressed in skin, where it contributes to the formation of the skin barrier and normal desquamation processes. Mutations in the LIPN gene have been associated with autosomal recessive congenital ichthyosis, indicating its essential function in skin lipid processing and barrier formation. As a member of the abhydrolase superfamily, it shares structural similarity with other classical lipases, possessing an α/β hydrolase fold and a catalytic triad in its active site. LIPN is considered a potential therapeutic target, particularly in skin disorders related to lipid metabolism, but no drugs are currently known to specifically target this enzyme[1]. *Note:* While information is available for lipase family member N, there are no known drugs or therapeutic interventions directly targeting LIPN as of this review. Most of the mechanistic and structural details in the references pertain to the broader lipase enzyme family[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipase family member N (LIPN).